[Immunological aspects of postoperative sepsis].
Beloborodova
N V
NV
Bachinskaia
E N
EN
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D019072:Antibiotic Prophylaxis; D001402:B-Lymphocytes / Q000276:immunology; D016207:Cytokines / Q000502:physiology; D004731:Endotoxins / Q000502:physiology; D006801:Humans; D018836:Inflammation Mediators / Q000502:physiology; D009102:Multiple Organ Failure / Q000209:etiology / Q000276:immunology; D011183:Postoperative Complications / Q000276:immunology* / Q000517:prevention & control / Q000628:therapy; D018805:Sepsis / Q000276:immunology* / Q000517:prevention & control / Q000628:therapy; D012773:Shock, Surgical / Q000517:prevention & control / Q000628:therapy; D018746:Systemic Inflammatory Response Syndrome / Q000276:immunology / Q000628:therapy; D013601:T-Lymphocytes / Q000276:immunology
D000276:Adjuvants, Immunologic; D000900:Anti-Bacterial Agents; D016207:Cytokines; D004731:Endotoxins; D018836:Inflammation Mediators